Jun Cai Bai
Amministratore Delegato presso Ambio Holdings, Inc.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Stephen John Kiel | M | 71 |
Ambio Product Management, Inc.
AmbioPharm (Switzerland) AG
AmbioPharm, Inc. (South Carolina)
 AmbioPharm, Inc. (South Carolina) Pharmaceuticals: MajorHealth Technology AmbioPharm, Inc. is a pharmaceutical manufacturing company based in South Carolina. The American company specializes in the production of pharmaceuticals. Brian Gregg has been the CEO of the private company since 2023.
Ambio, Inc.
 Ambio, Inc. Miscellaneous Commercial ServicesCommercial Services Ambio, Inc. is an American company that provides a platform for searching, comparing, requesting, and purchasing sustainable plastics from top material distributors and manufacturers. The private company is based in SC. The company's platform allows customers to quickly and easily find recycled and bio-based plastic materials at competitive prices, while also saving time by handling the search and logistics from start to finish.
Ambio Pharmaceuticals
 Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC.
Ambio Holdings, Inc.
 Ambio Holdings, Inc. Pharmaceuticals: MajorHealth Technology Ambio Holdings, Inc. operates as a pharmaceutical company which focuses on complex peptides. It develops processes for manufacturing peptides at small to large scale as active pharmaceutical ingredients used in New Chemical Entities and generic peptides by clients worldwide. The company was founded by Chris J. Bai in 2014 and is headquartered in North Augusta, SC. | 10 anni |
| Peter Joe Pitts | M | 65 |
Ambio Holdings, Inc.
Ambio Holdings, Inc. Pharmaceuticals: MajorHealth Technology Ambio Holdings, Inc. operates as a pharmaceutical company which focuses on complex peptides. It develops processes for manufacturing peptides at small to large scale as active pharmaceutical ingredients used in New Chemical Entities and generic peptides by clients worldwide. The company was founded by Chris J. Bai in 2014 and is headquartered in North Augusta, SC.
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 4 anni |
| Timothy Nieters | M | 52 |
AmbioPharm, Inc. (South Carolina)
AmbioPharm, Inc. (South Carolina) Pharmaceuticals: MajorHealth Technology AmbioPharm, Inc. is a pharmaceutical manufacturing company based in South Carolina. The American company specializes in the production of pharmaceuticals. Brian Gregg has been the CEO of the private company since 2023.
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 9 anni |
| Ling Yang | F | 44 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC.
Ambio Holdings, Inc.
Ambio Holdings, Inc. Pharmaceuticals: MajorHealth Technology Ambio Holdings, Inc. operates as a pharmaceutical company which focuses on complex peptides. It develops processes for manufacturing peptides at small to large scale as active pharmaceutical ingredients used in New Chemical Entities and generic peptides by clients worldwide. The company was founded by Chris J. Bai in 2014 and is headquartered in North Augusta, SC.
Ambio, Inc.
Ambio, Inc. Miscellaneous Commercial ServicesCommercial Services Ambio, Inc. is an American company that provides a platform for searching, comparing, requesting, and purchasing sustainable plastics from top material distributors and manufacturers. The private company is based in SC. The company's platform allows customers to quickly and easily find recycled and bio-based plastic materials at competitive prices, while also saving time by handling the search and logistics from start to finish. | 4 anni |
| Michael William Pennington | M | 62 |
AmbioPharm, Inc. (South Carolina)
AmbioPharm, Inc. (South Carolina) Pharmaceuticals: MajorHealth Technology AmbioPharm, Inc. is a pharmaceutical manufacturing company based in South Carolina. The American company specializes in the production of pharmaceuticals. Brian Gregg has been the CEO of the private company since 2023.
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 6 anni |
| Chong Sun Chung | M | 48 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 3 anni |
| Hao Zhang | M | 42 |
Ambio Holdings, Inc.
Ambio Holdings, Inc. Pharmaceuticals: MajorHealth Technology Ambio Holdings, Inc. operates as a pharmaceutical company which focuses on complex peptides. It develops processes for manufacturing peptides at small to large scale as active pharmaceutical ingredients used in New Chemical Entities and generic peptides by clients worldwide. The company was founded by Chris J. Bai in 2014 and is headquartered in North Augusta, SC.
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 4 anni |
| Craig Marshall Lea | M | 71 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 3 anni |
| Brian Gregg | M | - |
AmbioPharm, Inc. (South Carolina)
AmbioPharm, Inc. (South Carolina) Pharmaceuticals: MajorHealth Technology AmbioPharm, Inc. is a pharmaceutical manufacturing company based in South Carolina. The American company specializes in the production of pharmaceuticals. Brian Gregg has been the CEO of the private company since 2023. | 1 anni |
| Xiao Bo Lu | M | 51 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 3 anni |
| Shing Cheung Wong | M | 37 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Bo Liang Lou | M | 60 |
Shanghai Institute of Organic Chemistry
| 4 anni |
| Jin Fang Zhang | M | 62 |
Shanghai Institute of Organic Chemistry
| 4 anni |
| Hongbo Qiao | M | 59 |
Inner Mongolia University
| 4 anni |
| Ji Shuan Suo | M | 60 |
Inner Mongolia University
| 4 anni |
| Jay Fei Cheng | M | 58 |
Shanghai Institute of Organic Chemistry
| 2 anni |
| Fei Xiao | M | 61 |
Shanghai Institute of Organic Chemistry
| 3 anni |
| Dawei Ma | M | 60 |
Shanghai Institute of Organic Chemistry
| 3 anni |
| Hequn Yin | M | 60 |
Shanghai Institute of Organic Chemistry
| 1 anni |
| Yan Sheng Sun | M | 61 |
Inner Mongolia University
| 4 anni |
| Zhan Feng Cui | M | 60 |
Inner Mongolia University
| 4 anni |
| Li Wen Guo | M | 64 |
Inner Mongolia University
| 4 anni |
| Yi Qun Shi | M | - |
Shanghai Institute of Organic Chemistry
| 3 anni |
| Zhan Feng Cui | M | 62 |
Inner Mongolia University
| 4 anni |
| Guo Zhao Sun | M | - |
Inner Mongolia University
| 4 anni |
| Qi Lin Zhou | M | 67 |
Shanghai Institute of Organic Chemistry
| 3 anni |
| Xiao Bing Hui | M | 70 |
Inner Mongolia University
| 4 anni |
| Xiang Hua Xie | M | 61 |
Inner Mongolia University
| 4 anni |
| Yi Gang Wu | M | 64 |
Inner Mongolia University
| 4 anni |
| Ju Ying Zhang | M | 63 |
Inner Mongolia University
| 4 anni |
| Mao Zhang | M | 62 |
Inner Mongolia University
| 4 anni |
| Bing Xin Tian | M | 68 |
Inner Mongolia University
| 4 anni |
| Tong Qian Chen | M | - |
Shanghai Institute of Organic Chemistry
| 1 anni |
| Cui Ping Wang | F | 60 |
Inner Mongolia University
| 4 anni |
| Wu Jun Yang | M | 72 |
Shanghai Institute of Organic Chemistry
| 10 anni |
| Jian Hua Yang | M | 69 |
Shanghai Institute of Organic Chemistry
| 3 anni |
| Ya Qing Ma | M | 60 |
Inner Mongolia University
| 4 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Cina | 26 | 70.27% |
| Isole Cayman | 10 | 27.03% |
| Stati Uniti | 7 | 18.92% |
| Svizzera | 1 | 2.70% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Jun Cai Bai
- Contatti personali
